Personality changes, psychiatric disturbances and cognitive abnormalities frequently characterise the prodromal phase in Huntington's disease (HD), a devastating monogenic neurodegenerative disorder manifesting with abnormal motor movements and early death.
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Normal individuals have between 8-36 CAG repeats, coding for a polyglutamine (polyQ) stretch, at the N-terminus of the protein product of IT15, a 350 kDa protein called Huntingtin (HTT), whereas affected patients have more than 40 CAG repeats (HDCRG, 1993) .
The main neuropathological hallmark of HD is the selective degeneration of a subpopulation of striatal neurons, the GABAergic medium sized spiny neurons (MSSN), which leads to marked atrophy of the striatum, while other striatal neurons such as the large aspiny neurons and interneurons are relatively spared. Other affected neuronal populations include the pyramidal neurons of layers III and V of the cortex (Vonsattel, et al., 1985) . Microscopically, HD is characterised by the formation of intranuclear and neuropil aggregates where Nterminal fragments of mutant HTT (mHTT) with the expanded polyQ repeat localise. In general, intranuclear aggregates (NII) are bigger in size than neuropil aggregates, but the latter are related to mHTT toxicity, while larger NII probably form in an attempt of the cell to neutralise the toxic action of N-terminal soluble mHTT fragments (Arrasate, et al., 2004 , Saudou, et al., 1998 .
Since the discovery of the HD gene and mutation, the mechanism of mHTT toxicity to specific neuronal populations is still largely unclear. However, the subtle onset of behavioural and psychiatric symptoms long before motor impairment suggests that dysfunction of brain 4 connections controlling emotional and behavioural responses may characterise the early phases of the disease. Indeed synaptic and axonal dysfunction preceding cell loss have been shown, giving a possible explanation to early symptoms and potential novel therapeutic targets to defeat this devastating disorder.
Here we will review reports of early axonal dysfunction in HD patients and in vivo and in vitro models, we will discuss the evidence of the mechanisms underlying this dysfunction and we will indicate how targeting pathology at this level promises to open a new avenue in the therapeutic treatment of HD.
The normal role of huntingtin in the neurons
Although gain of a toxic function of mHTT primarily causes pathology, a loss of HTT normal function is a contributory factor to HD pathogenesis (Borrell-Pages, et al., . HTT is widely expressed in neuronal and non-neuronal tissues and is particularly abundant in neurons of the striatum and layers III and V of the cortex. Within the cell, it has a predominant cytoplasmic and perinuclear distribution, is associated to a variety of organelles including the Golgi complex and the mitochondrion and localises to vesicular structures such as microtubules and synaptic vesicles in neurites and synapses (Zuccato, et al., 2010) . HTT distribution in a "beads on a string" fashion in axons and their terminals suggests a role in vesicle axonal transport (DiFiglia, et al., 1995 , Sharp, et al., 1995 .
Hdh gene inactivation in mice results in developmental retardation and death between embryonic days 8.5 and 10.5 (Duyao, et al., 1995 , Nasir, et al., 1995 , Zeitlin, et al., 1995 , supporting a role in embryonic development and an antiapoptotic function of HTT.
Behavioural and cognitive defects in mice heterozygous for a targeted disruption in HTT exon 5 5 indicate a role of HTT in cognitive processes and suggest that partial loss of HTT function could contribute to the cognitive symptoms of HD patients (Nasir, et al., 1995) .
HTT is an essential component of the mitotic spindle (Godin, et al., 2010 ) and regulates nuclear processes such as gene transcription (Cha, 2007) . BDNF transcription in cortical neurons, that provide this trophic factor via the corticostriatal pathway to the striatum, depends on cytoplasmic HTT, which binds to and reduces the translocation of transcriptional regulator REST avoiding its binding to the silencing DNA element RE1/NRSE, its activation and suppression of BDNF transcription (Zuccato, et al., 2001 , Zuccato, et al., 2003 . Loss of this function could in part lead to decreased BDNF trophic support (Zuccato, et al., 2001) .
HTT is present at the postsynaptic density where it interacts with postsynaptic density protein Recently, a role of this interaction in mediating excitotoxicity in HD models has been shown (see below). Presynaptic roles of HTT, altered by the HD mutation, have also been documented (Rozas, et al., 2011) and could be affected by loss of normal HTT function.
(PSD-95). At this level it is involved in
In the cytoplasm and in the axon, wild type HTT through HAP1 interaction acts in association with microtubule-dependent molecular motors such as kinesins, dynein and dynactin in the regulation of axonal transport and vesicle trafficking (Caviston and Holzbaur, 2009) . In this way, HTT regulates the transport of synaptic vesicles, organelles, signalling and trophic factors such as BDNF (Gauthier, et al., 2004) and its loss impairs axonal transport in primary neurons (Her and Goldstein, 2008) . HTT function in vesicle trafficking is also mediated by palmitoylation (Yanai, et al., 2006) . HTT controls palmitoyl transferase activity of its 6 interaction partner huntingtin-interacting protein 14 (HIP14) (Huang, et al., 2004) , therefore regulating palmitoylation of substrates such as SNAP25 and GluR1 (Huang, et al., 2011 ) and providing another checkpoint on trafficking of these molecules.
Thus, vital cell processes are supported by the normal function of HTT and affected by its loss contributing to the overall toxicity in HD.
Dystrophic neurites precede neuronal loss in HD
As Alois Alzheimer observed in 1911, an invariable neuropathological finding in HD patients is the gradual and marked atrophy of the striatum, accompanied by the enlargement of the lateral ventricle, shrinkage of the cerebral cortex and the globus pallidus (GP), thinning of corpus callosum and abnormalities of hypothalamus (Vonsattel, et al., 1985) . Alzheimer's disease (AD) patients and maybe related to cognitive decline (Graveland, et al., 1985 , 1997) . This observation dissociates the formation of NII from axonal pathology in HD and highlights the independent role that dystrophic neurites/axons play in HD pathology (Sapp, et al., 1999) . Loss of enkephalin (ENK) immunoreactivity in the substantia nigra in the absence of cell loss (Waters, et al., 1988) and decreased density of ENK immunoreactive fibres in the external globus pallidus at presymptomatic age (Albin, et al., 1990 ) suggest degeneration of MSSN axonal projections.
Alterations in dendritic spine density may be related to dysfunction of the corticostriatal glutamatergic input to the neostriatum (Cudkowicz and Kowall, 1990) . MSSN receive their main excitatory input from two types of glutamatergic layer V cortical pyramidal neurons (Reiner, et al., 2010) . One type of neurons, with only intratelencephalic corticostriatal connections (IT-type), innervates direct pathway neurons, which show a higher resistance to degeneration in HD. The second type of neurons, which send their main axons to the brainstem via the pyramidal tract (PT-type), preferentially innervates indirect pathway striatal neurons, the first to degenerate in HD ( White matter abnormalities in early HD patients detected by magnetic resonance imaging (MRI) were correlated to cognitive dysfunction (Beglinger, et al., 2005) . Whether white matter change is secondary to early neuronal degeneration of functional circuits, or is a primary event, has not been fully clarified (Ross and Tabrizi, 2011) .
Taken together these studies suggest that white matter alterations and presence of dystrophic neurites occur before cell loss, possibly as a result of aggregation of mHTT N-terminal fragments in axons and block of axonal transport. It is important to further clarify the spatiotemporal relationship between neuronal death and neurite dysfunction. The answer to this question will have important therapeutic implications.
Neuronal dysfunction in HD models
Identification of HD gene and mutation makes possible to reproduce the cellular mechanisms of the pathology in cell and animal models (HDCRG, 1993) . Despite their limitations, these models provide a useful tool to study the cellular toxicity of the mutant protein in a short frame of time and a useful platform for testing potential pharmacological treatments. (Fig. 2) . Among them, transport motor proteins bind to microtubules and organelles at each side; however, the binding affinity and activity are highly regulated and ensure bidirectional trafficking of different organelles (Hirokawa and Takemura, 2005).
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Therefore, it is understandable that either of these components being malfunctional will certainly affect normal axonal transport of membrane organelles. In this section we will discuss whether and to which extent each of them affects axonal trafficking in HD.
Impaired transport machinery
In neurodegenerative diseases, including HD, protein misfolding is a common phenomenon, which is involved in protein aggregation. NII of mHTT frequently appear in the nuclei of HTT binds to HAP1, a protein that is transported in axons and associates with p150 
Conclusions and Perspectives
Neuronal dysfunction, neuritic dystrophy and synaptic abnormalities often precede neuronal death in HD patients and models and correlate with behavioural and cognitive impairment.
Neuropathological evidence of neuritic dysfunction, Ub and APP immunoreactivity and the presence of aggregates in the neuropil led to the hypothesis that axonal transport defects were the basis of neuronal dysfunction since the early studies (Jackson, et al., 1995) . Abnormalities Future therapeutic strategies in HD must aim at targeting early synaptic and axonal dysfunctions as well as at fighting neurodegeneration at the later stages of the pathology.
Axonal transport defects have to be corrected to achieve effective treatment. Solubilisation of axonal and cytoplasmic aggregates and removal of the blockage to axonal transport may be one such possibilities . Stabilisation of microtubules, rail of axonal transport, could be another way to improve defects in HD (Dompierre, et al., 2007) . In addition, new knowledge about the molecular players regulating axonal and synaptic degeneration is emerging quickly (Coleman and Freeman, 2010) . Shedding light on these 22 mechanisms may offer yet further therapeutic possibilities to sustain the normal activities of axons and synapses.
In conclusion, a vast body of evidence indicates that dysfunction of the synapse as well as the axon, particularly a disruption in axonal transport, may be the cause of several symptoms occurring early in HD, and therefore may offer a target for future treatment of this devastating disorder.
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